Annual long term liabilities:
$145.29M-$18.77M(-11.44%)Summary
- As of today (September 16, 2025), SUPN annual total long term liabilities is $145.29 million, with the most recent change of -$18.77 million (-11.44%) on December 31, 2024.
- During the last 3 years, SUPN annual long term liabilities has fallen by -$136.36 million (-48.41%).
- SUPN annual long term liabilities is now -48.41% below its all-time high of $281.65 million, reached on December 31, 2021.
Performance
SUPN Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$32.15M+$23.70M(+280.64%)Summary
- As of today (September 16, 2025), SUPN quarterly total long term liabilities is $32.15 million, with the most recent change of +$23.70 million (+280.64%) on June 30, 2025.
- Over the past year, SUPN quarterly long term liabilities has increased by +$12.72 million (+65.48%).
- SUPN quarterly long term liabilities is now -92.12% below its all-time high of $408.15 million, reached on March 31, 2020.
Performance
SUPN quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
SUPN Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.4% | +65.5% |
| 3 y3 years | -48.4% | -59.6% |
| 5 y5 years | +211.1% | -76.6% |
SUPN Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -48.4% | at low | -85.8% | +280.6% |
| 5 y | 5-year | -48.4% | +211.1% | -88.6% | +280.6% |
| alltime | all time | -48.4% | >+9999.0% | -92.1% | +774.2% |
SUPN Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $32.15M(+280.6%) |
| Mar 2025 | - | $8.45M(-94.2%) |
| Dec 2024 | $145.29M(-11.4%) | $145.29M(+861.1%) |
| Sep 2024 | - | $15.12M(-22.2%) |
| Jun 2024 | - | $19.43M(-29.0%) |
| Mar 2024 | - | $27.38M(-83.3%) |
| Dec 2023 | $164.07M(-27.8%) | $164.07M(+218.0%) |
| Sep 2023 | - | $51.59M(-40.3%) |
| Jun 2023 | - | $86.42M(-22.6%) |
| Mar 2023 | - | $111.60M(-50.9%) |
| Dec 2022 | $227.22M(-19.3%) | $227.22M(+190.1%) |
| Sep 2022 | - | $78.32M(-1.6%) |
| Jun 2022 | - | $79.56M(-3.5%) |
| Mar 2022 | - | $82.46M(-70.7%) |
| Dec 2021 | $281.65M(+62.8%) | $281.65M(+214.1%) |
| Sep 2021 | - | $89.67M(+2.5%) |
| Jun 2021 | - | $87.48M(+0.1%) |
| Mar 2021 | - | $87.36M(-49.5%) |
| Dec 2020 | $173.01M(+270.5%) | $173.01M(+115.6%) |
| Sep 2020 | - | $80.25M(-41.6%) |
| Jun 2020 | - | $137.48M(-66.3%) |
| Mar 2020 | - | $408.15M(+774.0%) |
| Dec 2019 | $46.70M(+9.0%) | $46.70M(-88.3%) |
| Sep 2019 | - | $399.94M(+0.8%) |
| Jun 2019 | - | $396.80M(+0.8%) |
| Mar 2019 | - | $393.72M(+818.6%) |
| Dec 2018 | $42.86M(+60.6%) | $42.86M(-88.2%) |
| Sep 2018 | - | $362.23M(+1.1%) |
| Jun 2018 | - | $358.37M(+1.2%) |
| Mar 2018 | - | $354.20M(+1227.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $26.69M(-28.0%) | $26.69M(-7.5%) |
| Sep 2017 | - | $28.86M(-8.2%) |
| Jun 2017 | - | $31.45M(-8.0%) |
| Mar 2017 | - | $34.19M(-7.8%) |
| Dec 2016 | $37.07M(-15.1%) | $37.07M(-7.5%) |
| Sep 2016 | - | $40.10M(-1.9%) |
| Jun 2016 | - | $40.89M(-2.2%) |
| Mar 2016 | - | $41.83M(-4.2%) |
| Dec 2015 | $43.69M(+13.0%) | $43.69M(+207.5%) |
| Sep 2015 | - | $14.21M(-68.8%) |
| Jun 2015 | - | $45.56M(-5.4%) |
| Mar 2015 | - | $48.15M(+24.5%) |
| Dec 2014 | $38.66M(-24.4%) | $38.66M(+1.5%) |
| Sep 2014 | - | $38.08M(-8.5%) |
| Jun 2014 | - | $41.63M(+0.6%) |
| Mar 2014 | - | $41.41M(-19.0%) |
| Dec 2013 | $51.13M(+280.6%) | $51.13M(-40.7%) |
| Sep 2013 | - | $86.24M(+7.7%) |
| Jun 2013 | - | $80.06M(+642.6%) |
| Mar 2013 | - | $10.78M(-19.8%) |
| Dec 2012 | $13.44M(+378.8%) | $13.44M(+265.4%) |
| Sep 2012 | - | $3.68M(-81.7%) |
| Jun 2012 | - | $20.10M(-12.7%) |
| Mar 2012 | - | $23.02M(-9.8%) |
| Dec 2011 | $2.81M(-96.3%) | $25.52M(-71.1%) |
| Sep 2011 | - | $88.32M(+16.0%) |
| Dec 2010 | $76.12M(+7348.3%) | $76.12M(+0.1%) |
| Sep 2010 | - | $76.01M(-0.0%) |
| Dec 2009 | $1.02M(-98.6%) | $76.02M |
| Dec 2008 | $75.61M | - |
FAQ
- What is Supernus Pharmaceuticals, Inc. annual total long term liabilities?
- What is the all time high annual long term liabilities for Supernus Pharmaceuticals, Inc.?
- What is Supernus Pharmaceuticals, Inc. annual long term liabilities year-on-year change?
- What is Supernus Pharmaceuticals, Inc. quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Supernus Pharmaceuticals, Inc.?
- What is Supernus Pharmaceuticals, Inc. quarterly long term liabilities year-on-year change?
What is Supernus Pharmaceuticals, Inc. annual total long term liabilities?
The current annual long term liabilities of SUPN is $145.29M
What is the all time high annual long term liabilities for Supernus Pharmaceuticals, Inc.?
Supernus Pharmaceuticals, Inc. all-time high annual total long term liabilities is $281.65M
What is Supernus Pharmaceuticals, Inc. annual long term liabilities year-on-year change?
Over the past year, SUPN annual total long term liabilities has changed by -$18.77M (-11.44%)
What is Supernus Pharmaceuticals, Inc. quarterly total long term liabilities?
The current quarterly long term liabilities of SUPN is $32.15M
What is the all time high quarterly long term liabilities for Supernus Pharmaceuticals, Inc.?
Supernus Pharmaceuticals, Inc. all-time high quarterly total long term liabilities is $408.15M
What is Supernus Pharmaceuticals, Inc. quarterly long term liabilities year-on-year change?
Over the past year, SUPN quarterly total long term liabilities has changed by +$12.72M (+65.48%)